Quality of Life and Impact of Endoscopic Sinus Surgery in Adult Patients With Cystic Fibrosis

Abstract

Background

Cystic fibrosis (CF) is the most common autosomal recessive disease in Caucasian population. Due to its pathological mechanism, chronic rhino sinusitis (CRS) associated or not with nasal polyposis usually occurs in adults and affects close to one-half of all CF patients. The goal of our work was to evaluate the impact of endoscopic sinus surgery (ESS) in the quality of life (QoL) of the CF patients and demonstrate an improvement of the functional outcomes in the patients undergoing the surgical procedure rather than in the not treated ones.

Methodology: We studied 54 adult patients affected by CF. Lund–Kennedy, Lund–Mackay scores, and Sino-Nasal Outcome Test-22 (SNOT-22) were analyzed.

Results

Twenty-two (40.7%) of the 54 CF patients underwent ESS. This group presented more likely complaints consistent with CRS. Lund–Kennedy and Lund–Mackay scores appeared higher in the ESS group: 10 (range of 6–12) and 16 (range of 12–20), respectively. SNOT-22 showed median values for non-ESS and ESS group of 17.5 (range of 3–68) and 44 (range of 10–73), respectively.

Conclusions

ESS represents the best option to improve clinical QoL of CF patients who do not response to conventional medical therapy.

Keywords

cystic fibrosis endoscopic sinus surgery chronic rhino sinusitis Sino-Nasal Outcome Test-22 quality of life

Get full access to this article

View all access options for this article.

References

Welsh

Tsui

Boat

Beauder

AL.

The metabolic and molecular basis of inherited diseases. Volume 3. 7th ed. New York, NY: McGraw-Hill, 1995;3799–3876

Sakano

Ribeiro

Barth

Condino Neto

Ribeiro

JD.

Nasal and paranasal sinus endoscopy, computed tomography and microbiology of upper airways and the correlations with genotype and severity of cystic fibrosis.

Int J Pediat Otorhinolaryngol. 2007; 71:41–50.

Mall

Galietta

LJ.

Targeting ion channels in cystic fibrosis.

J Cyst Fibros. 2015; 14:561–570.

Crockett

Mcgill

Healy

Friedman

Salkeld

LJ.

Nasal and paranasal sinus surgery in children with cystic fibrosis.

Ann Otol Rhinol Laryngol. 1987; 96:367–372.

Fokkens

Lund

Mullol

; European Position Paper on Rhinosinusitis and Nasal Polyps Group. European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl. 2007; 20:1–136.

Mainz

Koitschev

Management of chronic rhinosinusitis in CF.

J Cyst Fibros. 2009; 8(Suppl 1):S10–S14.

Kingdom

Lee

FitzSimmons

Cropp

GJ.

Clinical characteristics and genotype analysis of patients with cystic fibrosis and nasal polyposis requiring surgery.

Arch Otolaryngol Head Neck Surg. 1996; 122:1209–1213.

Henriksson

Westrin

Karpati

Wikstrom

Stierna

Hjelte

Nasal polyps in cystic fibrosis: clinical endoscopic study with nasal lavage fluid analysis.

Chest. 2002; 121:40–47.

Crosby

Adappa

ND.

What is the optimal management of chronic rhinosinusitis in cystic fibrosis?

Curr Opin Otolaryngol Head Neck Surg. 2014; 22:42–46.

10.

Keck

Lindemann

Simulation and air-conditioning in the nose. Laryngorhinootologie. 2010; 89:S1–S14.

11.

Berkhout

van Rooden

Rijntjes

Fokkens

el Bouazzaoui

Heijerman

HG.

Sinonasal manifestations of cystic fibrosis: a correlation between genotype and phenotype?

J Cyst Fibros. 2014; 13:442–448.

12.

Bhattacharyya

Clinical outcomes after endoscopic sinus surgery.

Curr Opin Allergy Clin Immunol. 2006; 6(3):167–171.

13.

Poetker

Smith

TL.

Adult chronic rhinosinusitis: surgical outcomes and the role of endoscopic sinus surgery.

Curr Opin Otolaryngol Head Neck Surg. 2007; 15(1):6–9.

14.

Davidson

Murphy

Mitchell

Smith

Light

Management of chronic sinusitis in cystic fibrosis.

Laryngoscope. 1995; 105(4 Pt 1):354–358.

15.

Ikeda

Oshima

Furukawa

et al . Restoration of the mucociliary clearance of the maxillary sinus after endoscopic sinus surgery. J Allergy Clin Immun. 1997; 99:48–52.

16.

Ikeda

Tanno

Tamura

et al . Endoscopic sinus surgery improves pulmonary function in patients with asthma associated with chronic sinusitis. Ann Otol Rhinol Laryngol. 1999; 108:355–359.

17.

Hopkins

Gillett

Slack

Lund

Browne

JP.

Psychometric validity of the 22-item Sinonasal Outcome Test.

Clin Otolaryngol. 2009; 34:447–454.

18.

Zielenski

Genotype and phenotype in cystic fibrosis.

Respiration. 2000; 67(2):117–133.

19.

Lund

Kennedy

DW.

Staging for rhinosinusitis.

Otolaryngol Head Neck Surg. 1997; 117(3):s35–s40.

20.

Rosbe

Jones

Rahbar

Lahiri

Auerbach

AD.

Endoscopic sinus surgery in cystic fibrosis: do patients benefit from surgery?

Int J Pediatr Otorhinolaryngol. 2001; 61:113–119.

21.

Dosanjh

Lakhani

Elashoff

Chin

Hsu

Hilman

A comparison of microbiologic flora of the sinuses and airway among cystic fibrosis patients with maxillary antrostomies.

Pediatr Transplant. 2000; 4(3):182–185.

22.

Henriquez

Wolfenden

Stecenko

DelGaudio

Wise

SK.

Endoscopic sinus surgery in adults with cystic fibrosis effect on lung function, intravenous antibiotic use, and hospitalization.

Arch Otolaryngol Head Neck Surg. 2012; 138(12):1167–1170.

23.

Keck

Rozsasi

Medium-term symptom out comes after paranasal sinus surgery in children and young adults with cystic fibrosis.

Laryngoscope. 2007; 117(3):475–479.

24.

Umetsu

Moss

King

Lewiston

NJ.

Sinus disease in patients with severe cystic fibrosis: relation to pulmonary exacerbation.

Lancet. 1990; 335:1077–1078.

25.

Gentile

Isaacson

Patterns of sinusitis in cystic fibrosis.

Laryngoscope. 1996; 106:1005–1009.

26.

Cepero

Smith

Catlin

Bressler

Furuta

Shandera

KC.

Cystic fibrosis—an otolaryngologic perspective.

Otolaryngol Head Neck Surg. 1987; 97:356–360.

27.

Ramsey

Richardson

MA.

Impact of sinusitis in cystic fibrosis. J Allergy Clin Immunol. 1992; 90: 547–552

28.

April

Tunkel

DeCelie-Germana

Zeitlin

Zinreich

SJ.

Computed tomography (CT) scan findings of the paranasal sinuses in cystic fibrosis.

Am J Rhinol. 1995; 9(5):277–280.

29.

Kang

Meotti

Bombardelli

Piltcher

Dalcin

PD.

Sinonasal characteristics and quality of life by SNOT-22 in adult patients with cystic fibrosis. Eur Arch Otorhinolaryngol. 2017; 274:1873.